Ronil Patel, MSc

Mr. Ronil Patel currently serves as Chief Business Officer at RevOpsis Therapeutics. Mr. Patel has over 15 years of experience in medical research, including biotech R&D, and global business development. He has been in ophthalmology since 2012 and has managed multiple clinical-stage assets that resulted in FDA approval, and are currently being commercialized in the US. Mr. Patel’s global business development experience involves in/out-licensing clinical-stage assets. He has executive leadership experience at both public and private companies and has been on teams that raised over $100 million in funding and exit deals valued at over $500 million. Mr. Patel holds a Master of Science degree with a specialization in Biotechnology from the Florida Institute of Technology.